Four Essential Assumptions for Causal Inference: Exchangeability, Positivity, No Interference, Consistency, and SUTVA
1. Exchangeability (Ignorability) 🔎 What it means: After adjusting for the observed covariates X, the treated and untreated groups are...
Causal Inference in Observational Research: Strategies, Assumptions, and Stata Tools
1 Why Observational Data Are Harder Than RCTs RCT privilege What you lose in an observational study Investigator controls treatment →...
Causal Inference in RCTs: ITT, CACE, and Estimands in Practice
Causal Inference inside an RCT – STATA-First Edition 0 Glossary of Key Abbreviations Short-form Stands for Meaning in this document R...
The Three E’s of Quantitative Research: Estimand, Estimator, Estimate
The Three E’s of Quantitative Research Term One-line definition Where it “lives” Simple example (blood-pressure drug) Estimand The...
Why Causality Matters: A Primer for Medical Research (Causal Inference)
1 Why Causality Matters Correlation → two variables move together. Causation → changing exposure X would change outcome Y for the...
Parametric Survival Analysis: Modelling Time-to-Event Data When the Hazard Has a Predictable Shape
Introduction Time-to-event studies frequently rely on Cox proportional-hazards regression because it requires no a priori specification...
Incidence Rate, Hazard, and Cox Regression: Distinctions in Time-to-Event Research
Table of Different slices of risk in time-to-event research : Concept Core question answered Typical notation (plain text) Where is it...
Cox Proportional Hazards Regression and Related Survival-Analysis Concepts
Introduction Clinical and public-health investigations often focus not only on whether an outcome occurs but also on when it occurs....
Survival Analysis in Stata: stset and sts – Kaplan-Meier
1. Declaring Survival Data with stset Purpose: The stset command in Stata designates your dataset as survival (time-to-event) data. This...
Time-to-Event (Survival) Analysis: Essentials for Clinical Researchers
Introduction Time-to-event analysis, commonly referred to as survival analysis, is a cornerstone methodology in clinical research and...
Merge vs Append in Stata: The Clinical Data Join Guide
Stata’s merge and append are among the first data management tools you’ll use in real clinical research. But when should you use each?...
Systemic Lupus Erythematosus (SLE) Guide: ANA-10 Rule, EULAR/ACR Criteria, and Treat-to-Target Plan
1. Diagnosis & Classification (2019 EULAR/ACR) Step How to Apply at the Bedside Key Numbers & Rules Entry criterion Confirm ANA by...
Inflammatory Myopathies (IIM): Polymyositis and Dermatomyositis “WEAK MUSCLE” Diagnosis, Staging, and Step-Care Treatment Plan By 2017 EULAR/ACR probability score
1 Pathophysiology & Clinical Presentation Key point Polymyositis (PM) Dermatomyositis (DM) Immune driver CD8⁺ T-cell–mediated myofibre...
Systemic Sclerosis (SSc) Diagnosis & Management: 2013 ACR/EULAR Score, FIBROSIS Checklist, and Treat-the-Phenotype Approach
1. Confirming the Diagnosis Step How you do it Exam pearls 1 A. Clinical suspicion Look for skin thickening , Raynaud phenomenon, puffy...
Rheumatoid Arthritis OSCE & Ward Guide: Diagnosis, DAMP-SAFE Workup, T2T ≤ 6 Management (ACR/EULAR 2023)
1. Making the Diagnosis Step-wise approach, you can reproduce on the wards or in a viva: What you do Why it matters “Exam-ready” tips 1....
Viral Hepatitis A B C D E: One-Page Guide to Diagnosis, Treatment, and Mnemonics (CDC & WHO 2024)
A Hepatitis A (HAV) Investigate Serum anti-HAV IgM → acute infection. Treatment Purely supportive ; almost always self-limited....
Viral Hepatitis B & C — Super-Pocket Investigation + Treatment Guide (2025)
1 Hepatitis B (HBV) Investigate Screen: HBsAg, anti-HBs, total anti-HBc ± IgM anti-HBc (if acute suspected) If HBsAg + : HBeAg, HBV DNA...
Hepatitis B and C Treatment Guide: When to Treat, What to Use, and Monitoring Essentials (WHO 2024, AASLD 2024)
Below is a stage-by-stage “when to treat & how to treat” roadmap for both hepatitis B (HBV) and hepatitis C (HCV). I highlight triggers...
Positive (+) and Negative (–) Viral Hepatitis B and Viral Hepatitis C Profiles: Practical Interpretation with WHO & CDC 2024–25 Updates (Viral Hepatitis Profiles)
Below is a self-contained, exam-ready deep dive on reading positive (+) and negative (–) viral-hepatitis profiles. I keep the...
Poisson Regression for Rate-Based Analysis in Clinical Research
Introduction In clinical epidemiology, quantifying how often events occur, such as complications, readmissions, or adverse effects, is...
Rate-Based Measures in Clinical Research: Cumulative Incidence vs Incidence Rate
Introduction In clinical research, the concept of rate underpins our ability to quantify the frequency of events, particularly in...